BioteQ to Present at Canaccord Adams’ 27th Global Growth Conference

VANCOUVER, BC – BioteQ Environmental Technologies Inc. (TSX:BQE) is pleased to announce that it will deliver a presentation at the 27th Annual Canaccord Adams Global Growth Conference in Boston, MA. Brad Marchant, President and CEO of BioteQ, is scheduled to present to leading institutional investment representatives on Tuesday, August 7, 2007, at the InterContinental Hotel in Boston at 1:00 pm EDT. A webcast of the presentation will be available via this link (live and replay):

Mr. Marchant will join executives from nearly 270 public and private companies for the conference, one of the longest-running institutional events focused exclusively on growth companies. “We look forward to showcasing our company to some of the country’s top growth investors at this year’s Growth Conference,” said Mr. Marchant. “This is an ideal venue where we can provide an important mid-year update of our growth strategy and achievements.”

“Long known as the Summer Seminar, this year we have changed the name of the event to better reflect the expanding international scope of companies and investors attending,” said Kevin Dunn, President and CEO of Canaccord Adams Inc. “It is our continued mission to deliver a top quality event for institutional clients and venture capitalists, connecting them with exciting growth companies. The conference will also afford corporate clients access to investing insights and valuable market information. Our goal is to provide a premier forum for sharing knowledge, discussing emerging trends and identifying investment opportunities for public and private companies, venture capitalists and institutional investors.”

The Canaccord Adams Global Growth Conference is one of the oldest and largest programs showcasing both publicly traded and privately held growth companies. Many of the presenting public companies are covered by Canaccord Adams’ global team of equity analysts. To learn more about the conference, please contact Nadine Miller at 617.371.3842 or

BioteQ Corporate Profile
BioteQ is establishing itself as a leader in the treatment of acid contaminated water through the use of its patented BioSulphide® Process and the ChemSulphide® Process as well as sulphate removal and control using its Sulf-IX™ technologies. Focused on the mining industry, BioteQ has partnered with leading metal producers including Phelps Dodge (Freeport), Breakwater, CVRD-INCO, Jiangxi Copper, Aditya Birla, Molymet and Xstrata as well as the US EPA and utilities operator EPCOR Water Services, to finance, design, build and operate mine site water treatment plants which recover saleable metals in addition to meeting ever stricter environmental regulations.

Canaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients a unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, our 225 professionals seek out emerging opportunities in our key sectors – Mining and Metals, Energy, Technology, Life Sciences, Real Estate, and Industrial Growth. Located in ten offices internationally, our experienced team generates focused, actionable ideas that identify opportunity and facilitate growth. Canaccord Adams, the international capital markets division of Canaccord Capital Inc., has operations in Toronto, London, Boston, Vancouver, New York, Calgary, Montreal, San Francisco, Houston and Chicago.

More information is available at

Canaccord Adams Inc., Member NASD/SIPC.

Canaccord Adams Limited is regulated and authorized by the Financial Services Authority and is a member of the LSE.

Canaccord Adams is a division of Canaccord Capital Corporation, Member IDA/CIPF.

Through its principal subsidiaries, Canaccord Capital Inc. (TSX:CCI)(AIM:CCI) is a leading independent full-service investment dealer in Canada, with capital markets operations in the United Kingdom and the United States of America. Canaccord is publicly traded on both the Toronto Stock Exchange and AIM, a market operated by the London Stock Exchange. Canaccord has operations in two of the principal segments of the securities industry: private client services and capital markets. Together these operations offer a wide range of complementary investment products, brokerage services and investment banking services to Canaccord’s private, institutional and corporate clients. Canaccord has approximately 1,570 employees worldwide in 31 offices, including 23 Private Client Services offices located across Canada. Canaccord Adams, the international capital markets division, has operations in Toronto, London, Boston, Vancouver, New York, Calgary, Montreal, San Francisco, Houston and Chicago.


On behalf of the Board of Directors

Brad Marchant